INJECTION SITE SWELLING

This adverse event was reported 60307 times

These drugs are most commonly taken by patients reporting INJECTION SITE SWELLING:

# Drug Count
0 ETANERCEPT 23157
1 ADALIMUMAB 7632
2 DUPILUMAB 4864
3 METHOTREXATE SODIUM 3488
4 METHOTREXATE 3444
5 EVOLOCUMAB 1710
6 GLATIRAMER ACETATE 1593
7 PREDNISONE 1458
8 FOLIC ACID 1434
9 IXEKIZUMAB 1414
See all common drugs associated with INJECTION SITE SWELLING

INJECTION SITE SWELLING is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE 9 0.2812
1 DEOXYCHOLIC ACID 295 0.1364
2 PEGVALIASE-PQPZ 357 0.0661
3 TECHNETIUM TC 99M OXIDRONATE 7 0.0569
4 IXEKIZUMAB 1414 0.0505
5 DEGARELIX 186 0.0473
6 FREMANEZUMAB-VFRM 315 0.0449
7 ASFOTASE ALFA 249 0.0445
8 COLLAGENASE CLOSTRIDIUM HISTOLYTICUM 202 0.0434
9 ETANERCEPT 23157 0.0405
See all drugs enriched for association with INJECTION SITE SWELLING